Ework Group AB (publ) (LON:0MCB)
107.00
0.00 (0.00%)
At close: Aug 1, 2025
Marinus Pharmaceuticals Cash Flow Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 117.59 | 138.51 | 129.03 | 139.19 | 97.99 | 69.34 | Upgrade |
Depreciation & Amortization | 24.55 | 25.66 | 25.32 | 17.92 | 24.19 | 24.71 | Upgrade |
Other Amortization | 18.55 | 18.55 | 15.7 | 12.46 | 10.38 | 6.66 | Upgrade |
Asset Writedown & Restructuring Costs | 0.04 | 0.04 | 0.11 | 0.18 | - | 0 | Upgrade |
Other Operating Activities | -9.61 | -2.55 | 0.75 | 21.83 | 10.54 | -18.02 | Upgrade |
Change in Accounts Receivable | 520.45 | 419.76 | 471.16 | -776.93 | -439.99 | 456.55 | Upgrade |
Change in Other Net Operating Assets | -429.44 | -423.85 | -478.05 | 695.71 | 365.18 | -160.7 | Upgrade |
Operating Cash Flow | 242.13 | 176.13 | 164.03 | 110.35 | 68.3 | 378.54 | Upgrade |
Operating Cash Flow Growth | 2479.14% | 7.38% | 48.64% | 61.58% | -81.96% | 1628.04% | Upgrade |
Capital Expenditures | -0.48 | -0.27 | -2.49 | -9.74 | -0.31 | -0.98 | Upgrade |
Sale of Property, Plant & Equipment | -0.1 | 0.42 | - | - | - | - | Upgrade |
Sale (Purchase) of Intangibles | -11.8 | -11.36 | -14.46 | -18.82 | -14.78 | -17.97 | Upgrade |
Other Investing Activities | - | - | - | - | - | -0 | Upgrade |
Investing Cash Flow | -12.38 | -11.21 | -16.95 | -28.56 | -15.09 | -18.95 | Upgrade |
Short-Term Debt Issued | - | - | - | 212.57 | - | - | Upgrade |
Total Debt Issued | -41.19 | - | - | 212.57 | - | - | Upgrade |
Short-Term Debt Repaid | - | -28.82 | -214.62 | - | -3.86 | - | Upgrade |
Long-Term Debt Repaid | - | -19.79 | -20.48 | -14.8 | -22.4 | -357.12 | Upgrade |
Total Debt Repaid | -49.58 | -48.61 | -235.09 | -14.8 | -26.26 | -357.12 | Upgrade |
Net Debt Issued (Repaid) | -90.77 | -48.61 | -235.09 | 197.77 | -26.26 | -357.12 | Upgrade |
Common Dividends Paid | -121.01 | -121.01 | -112.37 | -86.2 | -112.06 | - | Upgrade |
Other Financing Activities | -0 | 0.07 | 1.72 | -5.4 | 2.84 | - | Upgrade |
Financing Cash Flow | -211.78 | -169.55 | -345.74 | 106.18 | -135.48 | -357.12 | Upgrade |
Foreign Exchange Rate Adjustments | -1.48 | 0.64 | -1.9 | -10.46 | -2.35 | 0.05 | Upgrade |
Miscellaneous Cash Flow Adjustments | - | 0 | -0 | - | - | 0 | Upgrade |
Net Cash Flow | 16.49 | -4 | -200.56 | 177.51 | -84.62 | 2.53 | Upgrade |
Free Cash Flow | 241.65 | 175.85 | 161.54 | 100.62 | 67.99 | 377.56 | Upgrade |
Free Cash Flow Growth | 2597.27% | 8.86% | 60.55% | 47.99% | -81.99% | 1805.06% | Upgrade |
Free Cash Flow Margin | 1.67% | 1.12% | 0.94% | 0.63% | 0.52% | 3.08% | Upgrade |
Free Cash Flow Per Share | 13.98 | 10.17 | 9.34 | 5.82 | 3.94 | 21.90 | Upgrade |
Cash Interest Paid | 19.02 | 19.02 | 31.53 | 6.56 | 4.2 | 7.12 | Upgrade |
Cash Income Tax Paid | 41.75 | 39.16 | 37.02 | 14.58 | 16.28 | 33.6 | Upgrade |
Levered Free Cash Flow | 212.42 | 123.05 | 108.09 | 32.91 | 32.7 | 357.89 | Upgrade |
Unlevered Free Cash Flow | 224.34 | 138.1 | 131.96 | 37.01 | 35.32 | 362.34 | Upgrade |
Change in Net Working Capital | -85.66 | 13.25 | 13.8 | 79.22 | 63.4 | -290.98 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.